Aurora Cannabis (ACB) vs Niagen Bioscience (NAGE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aurora Cannabis (ACB) has outperformed Niagen Bioscience (NAGE) over the past year, losing 27.7% versus a loss of 62.1%. Over five years, NAGE leads with a -57.2% price change compared with -93.7% for ACB. Aurora Cannabis is the larger company by market cap ($282.4 million vs $215.2 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | NAGE |
|---|---|---|
| Share price | $4.46 | $2.72 |
| Market cap | $282.36M | $215.22M |
| 1-day change | -2.83% | +1.12% |
| YTD return | +5.69% | -57.23% |
| 1-year return | -27.71% | -62.12% |
| 5-year return | -93.66% | -57.23% |
| P/E ratio (TTM) | — | 14.32 |
| Forward P/E | — | 27.20 |
| EPS (TTM) | $-0.61 | $0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $7.95 |
| 52-week low | $2.56 | $2.61 |
| Distance from 52-week high | -33.08% | -65.79% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | — | +344.12% |
| Average volume | 1.36M | 589.35K |
| Shares outstanding | 63.31M | 79.13M |
| Employees | 1,028 | 117 |
| Sector | Healthcare | Consumer Defensive |
| Industry | Drug Manufacturers - Specialty & Generic | Packaged Foods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACB has outperformed NAGE by 34.4 percentage points over the past year.
- The two companies sit in different sectors: Aurora Cannabis in Healthcare and Niagen Bioscience in Consumer Defensive.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,028 employees
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Consumer Defensive · Packaged Foods · 117 employees
ACB vs NAGE FAQ
Which is bigger, Aurora Cannabis or Niagen Bioscience?
Aurora Cannabis (ACB) is larger, with a market capitalization of $282.36M compared with $215.22M for Niagen Bioscience (NAGE).
Which stock has performed better over the past year, ACB or NAGE?
ACB returned -27.71% over the past 12 months, compared with -62.12% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Niagen Bioscience in the same industry?
No. Aurora Cannabis is in the Healthcare sector, while Niagen Bioscience is in Consumer Defensive.